S&P 500
(-0.15%) 5 460.96 points
Dow Jones
(-0.11%) 39 068 points
Nasdaq
(0.11%) 17 737 points
Oil
(-0.05%) $80.79
Gas
(-3.45%) $2.66
Gold
(-0.78%) $2 312.70
Silver
(0.18%) $28.92
Platinum
(1.91%) $1 005.20
USD/EUR
(0.32%) $0.936
USD/NOK
(0.75%) $10.68
USD/GBP
(0.50%) $0.792
USD/RUB
(0.01%) $87.50

के लिए वास्तविक समय के अद्यतन Cytokinetics Inc [CYTK]

एक्सचेंज: NASDAQ क्षेत्र: Healthcare उद्योग: Biotechnology
BUY
77.78%
return 3.04%
SELL
22.22%
return 2.77%
अंतिम अद्यतन26 Jun 2024 @ 20:56

-2.06% $ 51.78

खरीदें 1278 min ago

@ $53.86

जारी किया गया: 25 Jun 2024 @ 23:38


वापसी: -3.86%


पिछला सिग्नल: Jun 25 - 22:52


पिछला सिग्नल: बेचें


वापसी: -0.66 %

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:56):
Our systems believe the stock currently is overvalued by -0.23% compare to its pairs and should correct downwards.

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases...

Stats
आज की मात्रा 341 436
औसत मात्रा 1.91M
बाजार मूल्य 5.94B
EPS $-1.330 ( Q1 | 2024-05-10 )
अगली कमाई की तारीख ( $-1.070 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -9.59
(Sector) 42.63
(Industry) 24.32
ATR14 $1.680 (3.24%)
AADI -2.65%
ABCL 1.79%
ABCM 0.04%
ABEO -2.37%
ABIO -1.68%
ABOS 1.64%
ABSI 2.89%
ABUS -2.24%
ABVX -3.53%
ACAD -0.45%
ACER -17.95%
ACET -4.44%
ACGN 1.29%
ACHL -4.15%
ACHV -1.72%
ACIU -0.50%
ACLX -0.09%
ACRV -4.79%
ACST -1.63%
ACXP 0.65%
ADAG 4.64%
ADAP -2.79%
ADGI 0.87%
ADIL 0.54%
ADMA -2.59%
ADPT -0.30%
ADTX -3.47%
ADVM -4.29%
ADXN -1.60%
AEON -3.74%
AEZS -3.51%
AFMD -1.40%
AGEN -1.58%
AGIO -2.04%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -3.54%
AKRO -2.77%
AKTX 4.08%
AKUS 0.00%
ALBO 0.00%
ALDX -2.25%
ALEC -3.90%
ALGS -2.41%
ALKS -0.21%
ALLK -8.90%
ALLO -6.46%
ALLR -3.25%
ALNA 3.16%
ALNY 1.72%
ALPN 0.02%
ALPX 0.00%
ALRN -1.67%
ALT -9.38%
ALVR -0.57%
ALXN 0.00%
ALXO -10.43%
ALZN 4.78%
AMRN 0.26%
AMTI -3.13%
ANAB 0.80%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX -0.65%
ANPC -3.15%
APGE -1.04%
APGN 8.48%
APGNW 30.65%
APLM 1.56%
APLS 0.07%
APLT -4.28%
APM -1.47%
APOP 0.38%
APRE 2.29%
APTO 4.70%
APTX 3.17%
APVO 0.18%
ARAV -13.39%
ARCT -3.86%
ARDS -14.23%
ARDX -0.95%
ARGX -0.80%
ARNA 0.00%
ARPO -0.90%
ARQT -0.52%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.19%
ARWR -1.86%
ASLN -4.71%
ASMB -5.19%
ASND -0.91%
ATAI -1.46%
ATHA 5.94%
ATHE 1.12%
ATHX -33.50%
ATNF 0.99%
ATOS 2.91%
ATRA -2.89%
ATXI 1.93%
ATXS -1.22%
AUPH -0.99%
AURA -0.15%
AUTL -1.87%
AVBP -2.86%
AVEO 0.00%
AVIR -0.15%
AVRO -1.41%
AVTE -4.86%
AVTX -1.25%
AVXL -2.72%
AXLA 0.00%
AXSM -1.73%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.68%
BCAB 3.59%
BCDA -2.07%
BCDAW -41.77%
BCEL 0.00%
BCLI 2.60%
BCRX 1.32%
BCTX 8.12%
BCTXW -22.52%
BCYC 0.55%
BDRX -5.14%
BDTX -0.85%
BEAM 0.08%
BFRA -2.91%
BGNE -2.19%
BIOR -3.40%
BIVI 1.18%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.85%
BLTE -0.62%
BLU 0.03%
BLUE -0.54%
BMEA -9.60%
BMRN 0.39%
BNOX -2.22%
BNTC -2.11%
BNTX -1.24%
BOLD -7.90%
BOLT -0.18%
BPMC -1.27%
BPTH 1.86%
BPTS -13.47%
BRNS -0.74%
BRTX -2.36%
BTAI 23.72%
BTTX 53.33%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 3.33%
CABA 0.28%
CADL -0.97%
CALA 0.00%
CALC -1.77%
CALT -0.59%
CAPR -2.80%
CARA -0.63%
CARM 12.13%
CASI -1.67%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -7.00%
CCCC -5.41%
CCXI 0.00%
CDAK 0.00%
CDIO -2.02%
CDIOW 24.00%
CDMO -2.96%
CDMOP 0.04%
CDT -10.57%
CDTTW -39.60%
CDTX -1.92%
CDXC -0.41%
CDXS 4.31%
CELC -3.85%
CELU -1.50%
CELUW 11.80%
CERC -1.68%
CERE -0.82%
CERO -3.60%
CEROW -10.18%
CFRX -27.95%
CGEM -2.74%
CGEN -3.31%
CGON -0.29%
CGTX -4.55%
CHMA -6.00%
CHRS -0.32%
CINC 0.00%
CING -3.64%
CINGW 34.95%
CKPT -2.88%
CLBS -16.75%
CLDX -2.32%
CLGN 0.34%
CLLS -4.15%
CLNN 2.42%
CLNNW 0.00%
CLRB 7.24%
CLSD -2.90%
CLSN -0.68%
CLVS 0.00%
CMMB -0.01%
CMND 3.63%
CMPI 0.00%
CMPX -8.03%
CMRA 0.00%
CMRAW 33.33%
CMRX -2.71%
CNCE 0.00%
CNSP -40.07%
CNST 0.00%
CNTA -0.51%
CNTB -2.25%
CNTX -6.85%
COCP -2.02%
COEPW 32.45%
COGT -2.89%
CORT 2.17%
COYA -1.46%
CPRX -0.76%
CRBP -1.85%
CRBU -4.83%
CRDF -2.21%
CRGX 1.28%
CRIS -0.38%
CRNX -5.96%
CRSP 1.04%
CRTX 2.63%
CRVO -2.50%
CRVS 1.12%
CSBR -1.59%
CTCX -1.63%
CTIC 0.06%
CTMX -2.50%
CTNM -0.65%
CTXR 0.04%
CUE 3.63%
CVAC -1.98%
CVKD 0.15%
CWBR 2.80%
CYAD -12.96%
CYCC 9.75%
CYCCP 5.49%
CYCN 0.43%
CYT -2.27%
CYTK -2.06%
CYTO -2.73%
DARE 6.54%
DAWN 0.30%
DBTX -0.81%
DBVT -2.08%
DFFN 10.28%
DICE 0.06%
DMAC 34.47%
DNLI -1.92%
DNTH -6.31%
DOMH -1.58%
DRMA -1.10%
DRMAW -1.25%
DRNA 0.00%
DRTS 1.85%
DRTSW 0.00%
DRUG 0.95%
DSGN -1.51%
DTIL 1.36%
DYAI 9.68%
EARS -1.77%
EDIT -2.52%
EDSA -1.00%
EFTR 7.18%
EFTRW -51.85%
EIGR -9.21%
ELAB -1.00%
ELDN 7.98%
ELEV -4.56%
ELOX 7.69%
ELTX -0.88%
ELVN -4.52%
ELYM 0.77%
ENGN 1.67%
ENGNW 0.12%
ENLV 2.54%
ENOB 1.79%
ENSC 5.11%
ENTA -0.49%
ENTO -0.07%
ENTX 0.69%
ENVB 1.10%
EPIX -0.10%
EPRX -2.97%
EPZM 0.00%
EQ 0.86%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.04%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 87.05%
ETNB -0.51%
ETON -0.30%
ETTX 0.00%
EVAX -2.14%
EVGN 3.88%
EVLO 0.00%
EWTX 0.00%
EXAI -0.95%
EXEL -0.25%
EYEG -0.69%
EYEN 1.51%
EYPT -0.12%
FATE -8.05%
FBIO 0.59%
FBIOP 0.92%
FBLG -16.60%
FBRX -0.04%
FDMT -4.77%
FENC -1.29%
FGEN -4.70%
FHTX 1.43%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -2.58%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.47%
FULC -3.34%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.29%
GANX -1.42%
GBIO -2.12%
GBT 0.01%
GDTC 0.50%
GERN -3.98%
GHRS -1.60%
GLMD -2.15%
GLPG -2.26%
GLSI 2.80%
GLTO -0.57%
GLUE -1.58%
GLYC -10.03%
GMAB -0.47%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -0.52%
GNLX 0.89%
GNPX 0.98%
GNTA 3.94%
GOSS -7.81%
GOVX 3.65%
GOVXW -49.04%
GPCR -7.01%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 0.00%
GRTX 0.00%
GTHX 0.68%
GUTS -5.31%
GXGXW 41.67%
GYRE -7.16%
HALO -0.89%
HARP 0.09%
HCWB -3.75%
HEPA 2.80%
HGEN -84.62%
HILS 5.66%
HLVX -1.91%
HOOK 1.13%
HOTH -2.70%
HOWL -2.14%
HRMY 0.83%
HRTX 1.97%
HSTO 0.00%
HUMA 1.22%
HUMAW -0.01%
IBRX -4.14%
ICCC 0.22%
ICPT 0.21%
ICU 17.92%
ICUCW 20.20%
ICVX -0.91%
IDRA -23.04%
IDYA -1.52%
IFRX -2.66%
IGMS -0.15%
IKNA 0.60%
IKT 1.42%
IMAB -0.87%
IMCR -2.60%
IMGN 0.02%
IMGO 0.00%
IMMP 4.55%
IMMX -6.90%
IMNM -1.56%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX -0.84%
IMTX -1.58%
IMTXW 6.00%
IMUX 1.56%
IMV 0.00%
IMVT -3.68%
INAB 0.59%
INBX 0.47%
INCY -0.94%
INDP 11.07%
INFI -52.38%
INKT -0.01%
INM -2.20%
INMB 2.66%
INO -1.56%
INSM -0.89%
INTS -2.75%
INVA 0.22%
INZY 1.15%
IOBT -11.02%
IONS 0.04%
IOVA -2.25%
IPA 2.46%
IPHA 5.58%
IPSC -1.95%
IRON -2.35%
ISEE 0.38%
ITOS -1.57%
ITRM 1.67%
IVA 6.96%
IVVD -3.72%
JAGX 1.04%
JANX -4.22%
JAZZ -0.53%
JNCE 0.00%
JSPR -5.92%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.94%
KALV -1.90%
KDNY 0.22%
KMPH -0.34%
KNSA -2.71%
KNTE -0.38%
KOD -7.11%
KPRX 0.96%
KPTI -1.38%
KRBP -10.00%
KRON 1.05%
KROS -1.18%
KRRO -6.34%
KRTX 0.03%
KRYS -0.79%
KTRA 16.29%
KTTA 8.16%
KTTAW 0.92%
KURA -1.78%
KYMR -2.22%
KYTX -3.49%
KZIA 5.16%
KZR -1.49%
LABP 0.57%
LBPH -0.93%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.65%
LENZ -4.01%
LEXX 0.00%
LEXXW -14.63%
LGND -1.30%
LGNDV 0.00%
LGVN -9.04%
LIAN -8.28%
LIFE 2.70%
LIPO -7.10%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 0.78%
LPCN -3.16%
LPTX -1.10%
LQDA -0.24%
LRMR -1.92%
LSTA -4.06%
LTRN 0.50%
LUMO -1.32%
LVTX 0.00%
LXEO -4.33%
LXRX -2.35%
LYEL -34.92%
LYRA 2.71%
MACK 0.10%
MBIO -9.40%
MBRX -1.72%
MCRB 1.12%
MDGL -2.42%
MDNA -13.16%
MDWD 0.10%
MDXG -2.58%
MEIP -0.13%
MESO -1.78%
MGNX -2.91%
MGTA -7.74%
MGTX -2.68%
MGX -2.68%
MIRM -1.42%
MIRO 0.59%
MIST 1.54%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX -0.76%
MLYS -5.55%
MNKD -1.05%
MNMD 0.21%
MNOV 2.11%
MNPR -5.01%
MOLN 0.28%
MOR 1.06%
MORF -3.67%
MREO -4.43%
MRKR 2.68%
MRNA -5.04%
MRNS -4.04%
MRSN -2.62%
MRTX -0.17%
MRUS 0.25%
MRVI -1.97%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -1.08%
MYMD 8.38%
NAMS 1.37%
NAMSW 0.43%
NAUT 1.14%
NBRV 0.71%
NBSE -1.56%
NBTX 8.61%
NCNA 1.09%
NERV -1.87%
NEXI 2.60%
NGM -1.28%
NGNE -1.98%
NKGN 5.88%
NKGNW 8.00%
NKTR -3.27%
NKTX -4.57%
NLSP -2.77%
NLSPW 26.67%
NMRA -0.46%
NMTR -42.97%
NOVN -24.84%
NRBO 12.09%
NRIX -0.58%
NRSN -3.63%
NRSNW 0.00%
NRXP -4.14%
NRXPW 18.33%
NRXS 4.82%
NTBL 5.06%
NTEC -12.45%
NTHI 0.00%
NTLA -6.27%
NTRBW -31.07%
NUVL -1.93%
NVAX -1.89%
NVCT 3.59%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 0.40%
OABIW -10.06%
OBIO -2.99%
OBSV 0.00%
OCEA 0.00%
OCGN 4.24%
OCS -1.02%
OCUL -1.91%
OCUP 1.97%
ODT -4.27%
OKYO 1.51%
OLMA -5.12%
OMER -0.90%
OMGA 5.45%
ONCO 4.90%
ONCR -3.08%
ONCS 31.87%
ONCT -1.87%
ONCY 0.99%
ONTX -0.47%
ONVO 0.99%
OPNT 0.00%
OPT 2.57%
ORGS -4.53%
ORIC -3.56%
ORMP 15.09%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.81%
OVID -1.43%
OYST 0.00%
PALI -0.87%
PASG -1.30%
PBLA -7.50%
PBM -7.49%
PBYI 1.69%
PCSA 0.00%
PCVX -0.37%
PDSB -1.11%
PEPG 0.48%
PGEN -3.59%
PHAR 1.51%
PHAS 0.00%
PHAT -1.06%
PHIO -3.57%
PHIOW 36.47%
PHVS -7.22%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -0.73%
PLUR 6.01%
PMN 0.72%
PMVP -1.19%
PNT 0.16%
PPBT -4.26%
PRAX 0.95%
PRDS 0.93%
PRLD 0.00%
PROG -3.47%
PROK 0.45%
PRQR -0.01%
PRTA -2.36%
PRTC 0.49%
PRTG -0.50%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -5.11%
PSTX -1.16%
PTCT -0.28%
PTE -0.82%
PTGX -1.50%
PTIXW -49.04%
PULM 2.60%
PXMD 0.00%
PYPD 0.07%
PYXS 2.61%
QLGN -3.72%
QNCX 5.70%
QNRX 0.37%
QSI -11.84%
QSIAW -3.13%
QTTB -4.54%
QURE -0.34%
RAIN -1.63%
RANI 6.42%
RAPT -2.92%
RARE 1.10%
RCKT -8.09%
REGN -0.66%
RENB -3.11%
REPL -2.49%
RETA 0.02%
REUN -0.89%
REVB -1.40%
REVBU 3.46%
REVBW 4.38%
RGLS -4.91%
RGNX -5.40%
RIGL -3.28%
RLAY -4.38%
RLMD 0.33%
RLYB -0.34%
RNA -0.42%
RNAC -5.65%
RNAZ -0.96%
RNXT 1.88%
ROIV -2.08%
ROIVW 4.56%
RPHM -0.31%
RPRX 0.30%
RPTX -2.05%
RUBY 2.70%
RVLP -32.05%
RVMD -1.15%
RVMDW -30.00%
RVNC 1.70%
RVPH -1.19%
RVPHW 1.62%
RXDX 0.09%
RXRX -3.46%
RYTM -6.25%
RYZB 0.02%
RZLT 1.29%
SABS -1.37%
SABSW -11.81%
SAGE 1.47%
SANA -4.15%
SAVA -0.26%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 5.50%
SCPH -0.51%
SCPS 0.00%
SEEL -4.09%
SEER -0.44%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -1.23%
SGMT -2.12%
SGTX -2.56%
SIOX 22.63%
SLDB -5.00%
SLGL 4.00%
SLN -4.21%
SLNO -2.71%
SLRX 5.23%
SLS -2.99%
SMMT -2.62%
SNDX 0.77%
SNGX -3.02%
SNPX -0.81%
SONN -1.08%
SPPI -0.49%
SPRB 0.30%
SPRC -4.17%
SPRO 0.04%
SRNE -34.00%
SRPT -1.86%
SRRA 0.00%
SRRK -2.48%
SRZN -2.45%
STAB 0.00%
STOK -4.80%
STRO -2.51%
STSA 0.00%
STTK -4.78%
SURF -0.93%
SVRA -3.29%
SWTX 0.33%
SYBX -1.94%
SYRS -1.72%
TALS -0.73%
TARA -8.06%
TARS 0.12%
TBPH 0.54%
TCBP 2.74%
TCDA 0.00%
TCON -2.43%
TCRR 0.00%
TCRT 1.59%
TCRX 2.58%
TECH -0.19%
TENX -1.27%
TERN -7.31%
TFFP -3.05%
TGTX -2.71%
THRX 0.12%
TIL -0.20%
TLC 0.00%
TLSA -4.13%
TNGX -2.16%
TNXP -5.76%
TNYA -8.76%
TPST 2.91%
TRDA -3.86%
TRVI 1.15%
TRVN 5.02%
TSHA -23.89%
TSVT -3.19%
TTNP -9.27%
TVTX 0.63%
TYRA -7.98%
UBX -2.12%
UNCY -3.38%
URGN -1.45%
UTHR -0.25%
VACC 11.36%
VALN -2.89%
VAXX 87.50%
VBIV 0.78%
VBLT -8.77%
VCEL -0.09%
VCNX 10.35%
VCYT -1.23%
VERA -2.81%
VERU 0.78%
VERV -2.86%
VIGL 5.11%
VINC 1.62%
VIR 0.43%
VIRI -1.57%
VIRX 2.40%
VKTX -1.34%
VLON -13.04%
VNDA -2.36%
VOR -2.42%
VRCA 0.28%
VRDN -4.23%
VRNA -1.00%
VRPX 0.38%
VRTX 0.35%
VSTM -3.74%
VTGN -0.46%
VTVT -2.97%
VTYX -0.21%
VXRT -2.26%
VYGR -1.66%
VYNE -3.47%
VYNT 7.78%
WINT -3.24%
WVE -4.40%
XBIO 0.93%
XBIT 1.78%
XCUR 3.58%
XENE -2.91%
XERS 2.62%
XFOR 3.71%
XLO 1.58%
XLRN 0.00%
XNCR 0.34%
XOMA -3.14%
XOMAO 0.36%
XOMAP -0.82%
XRTX -8.92%
YMAB -1.71%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -3.29%
ZNTL -2.86%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-25 Malik Fady Ibraham Buy 5 300 Common Stock
2024-06-25 Malik Fady Ibraham Sell 2 000 Common Stock
2024-06-25 Malik Fady Ibraham Sell 5 300 Common Stock
2024-06-25 Malik Fady Ibraham Sell 5 300 Non-Qualified Stock Option (Right to Buy)
2024-06-17 Parshall B Lynne Buy 5 000 Common Stock
INSIDER POWER
4.79
Last 99 transactions
Buy: 566 133 | Sell: 523 580
सहसंबंध (AI algo v.1.1b): Overvalued: -0.23% $51.90 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: 0.34 (neutral)
छोटा: 0.08 (neutral)
Signal:(57) Neutral

Cytokinetics Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
OZEM1
KLXE0.905
AGRI0.903
BNAI0.901
BRLT0.9
FWRD0.897
SVC0.893
PZZA0.892
BCTX0.89
CHUY0.888
10 सबसे अधिक नकारात्मक सहसंबंध
RFAIU-0.918
GOGL-0.9
GODN-0.893
IBKR-0.892
AFAR-0.89
ACGL-0.886
WING-0.884
BYNO-0.882
SFM-0.877
APXI-0.877

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Cytokinetics Inc सहसंबंध - मुद्रा/वस्त्र

The country flag -0.21
( neutral )
The country flag 0.21
( neutral )
The country flag 0.00
( neutral )
The country flag 0.21
( neutral )
The country flag 0.00
( neutral )
The country flag -0.12
( neutral )

Cytokinetics Inc वित्तीय

Annual 2023
राजस्व: $7.53M
सकल लाभ: $-4.36M (-57.93 %)
EPS: $-5.45
FY 2023
राजस्व: $7.53M
सकल लाभ: $-4.36M (-57.93 %)
EPS: $-5.45
FY 2022
राजस्व: $94.59M
सकल लाभ: $-146.23M (-154.59 %)
EPS: $-4.48
FY 2021
राजस्व: $70.43M
सकल लाभ: $0.00 (0.00 %)
EPS: $-2.68

Financial Reports:

No articles found.

Cytokinetics Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Cytokinetics Inc

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure; and reldesemtiv, a skeletal muscle troponin activator, which is in Phase III clinical trial to treat amyotrophic lateral sclerosis and spinal muscular atrophy. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy; and CK-3772271, a small molecule cardiac myosin inhibitor that is in Phase I clinical trial. Cytokinetics, Incorporated has a strategic alliance with Astellas Pharma Inc. The company was incorporated in 1997 and is headquartered in South San Francisco, California.

के बारे में लाइव सिग्नल्स

इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।

लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं

Total Execution Time: 1.2008979320526 seconds
Number of API calls: 3
Number of DB calls: 9